Modeling VOC-odor exposure risk in livestock buildings.
This paper describes a novel idea of linking models of exposure, internal dosimetry, and health effects. Risk assessment approach that integrates predicted odor caused by volatile organic compounds (VOC-odor) of toluene/xylene concentrations in human tissues leads to predict exposure risks in livestock buildings. First, VOC transport model was developed to calculate airborne toluene/xylene concentrations. Based on a physiologically based pharmacokinetic (PBPK) model, concentrations within five compartments representing lung, liver, fat, slowly perfused tissues, and rapidly perfused tissues could be quantified. By using a pharmacodynamic (PD) Hill model, we can optimally fit data from rat and human experiments to reconstruct dose-response relationships for accounting human health effects from nose poke and eye irritation. Results demonstrated that peak tissue concentration occurring at 5-10h in that fat contains the highest concentration than other tissues at around 4ppm of toluene and 1.8ppm of xylene. The EC(10) values are 114 and 232ppm, whereas expected risks are estimated to be 0.71% and 0.26% of human exposure to toluene and xylene, respectively. Risk analyses indicate that inhalation exposure in livestock buildings poses no significant threat to human health under the present environmental conditions. This method provides a rigorous and effective approach to relate target tissue concentration to human nose poke or eye irritation. We suggest that our probabilistic framework and methods be taken seriously because they produce general conclusions that are more robust and could offer a risk-management framework for discussion of future establishment of limits for respiratory exposure to VOC-odor.
Liang
Huang-Min
HM
Department of Bioenvironmental Systems Engineering, National Taiwan University, Taipei, Taiwan 10617, ROC.
Liao
Chung-Min
CM
D000393:Air Pollutants / Q000493:pharmacokinetics / Q000633:toxicity; D016902:Air Pollution, Indoor / Q000009:adverse effects; D000818:Animals; D000829:Animals, Domestic; D005123:Eye / Q000187:drug effects; D006799:Housing, Animal; D006801:Humans; D019570:Inhalation Exposure / Q000009:adverse effects*; D008954:Models, Biological; D009666:Nose / Q000187:drug effects; D018570:Risk Assessment; D014050:Toluene / Q000493:pharmacokinetics / Q000633:toxicity*; D014835:Volatilization; D014992:Xylenes / Q000493:pharmacokinetics / Q000633:toxicity*
D000393:Air Pollutants; D014992:Xylenes; D014050:Toluene